If you're behind a web filter, please make sure that the domains *.and *.are unblocked. Hydroxychloroquine (Plaquenil) is considered a disease-modifying anti-rheumatic drug (DMARD). Bupropion and plaquenil Stopping plaquenil suddenly Hydroxychloroquine does not require regular blood tests routinely; however, people taking it should have a baseline ophthalmic examination in a hospital eye department, ideally with a colour retinal photograph and spectral domain optical coherence tomography SD-OCT scans of the macula. After five years of therapy they should be referred for. Hydroxychloroquine is in a class of drugs called antimalarials. It is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. It may prevent joint damage and reduce the risk of long-term disability. It can decrease the pain and swelling of arthritis. Hydroxychloroquine nclex Hydroxychloroquine Reviews Everyday Health, Hydroxychloroquine MedlinePlus Drug Information Plaquenil causing alopeciaChloroquine and proguanil brand namePlaquenil effects on liver Brilliant Nurse® is a learning platform and career bridge for all nurses and allied healthcare folks. Pass your NCLEX and other nursing + healthcare exams and get an awesome career ahead! Reach out to our chat-friendly support for all your questions. NCLEX Immunologic disorders - Brilliant Nurse®. Hydroxychloroquine Plaquenil. Hydroxychloroquine Professional Patient Advice -. A 25-year-old client taking hydroxychloroquine Plaquenil for rheumatoid arthritis reports difficulty seeing out of her left eye. Correct interpretation of this assessment finding indicates which of the following? 1. Development of a cataract. 2. Possible retinal degeneration. 3. Part of the disease process. 4. A coincidental occurrence. Hydroxychloroquine Tamoxifen may enhance the adverse/toxic effect of Hydroxychloroquine. Specifically, concomitant use of tamoxifen and hydroxychloroquine may increase the risk of retinal toxicity. Monitor therapy. Idelalisib May increase the serum concentration of CYP3A4 Substrates High risk with Inhibitors. Avoid combination Explanation A Hydroxychloroquine Plaquenil is an antimalarial drug used in SLE to reduce the frequency of acute episodes of SLE. The primary concern with Plaquenil is retinal toxicity and possible irreversible blindness. Cushingoid effects are a concern with corticosteroid therapy.